NASDAQ: REGN - PDUFA date update
Read more
Next-Generation RNA company Inverna Therapeutics is launched
The newly formed company will use splicing technology to develop safer and more effective RNA medicines for severe genetic illnesses On January 7, 2025, Argobio shared the exciting news about the launch of Inverna Therapeutics, a new biotech company based in Denmark that focuses on innovative RNA therapeutics, co-founded with
The Japanese MHLW Approves Takeda's HYQVIA Subcutaneous Injection
HYQVIA is the first and only facilitated subcutaneous immunoglobulin licensed in Japan to treat Agammaglobulinemia or Hypogammaglobulinemia On December 27, 2024, Takeda shared that the Japanese Ministry of Health, Labour and Welfare (MHLW) has given the green light to HYQVIA [ Human Immune Globulin Infusion 10% Human with Recombinant Human Hyaluronidase]
Roche reports the Prasinezumab aids in early-stage Parkinson's
The main goal of the Phase IIb study wasn't met with statistically significant results, but there is still some good news On Dec. 18, 2024, Roche shared results from a Phase IIb study (PADOVA) where prasinezumab, an investigational monoclonal antibody (mAb), did not meet the study’s primary
Novo Nordisk is Funding New Manufacturing Facility in Denmark
Novo Nordisk will establish a modular, adaptable production facility in Odense, Denmark Novo Nordisk announced a $1.2 billion production plant in Odense, Denmark, on Dec. 16, 2024. The facility will house present and future hemophilia treatment products. In a press release, Novo Nordisk said this investment is its first